Editor in Chief Dr KK Aggarwal, Padma Shri Awardee Dated:11 January,2020
Scientists find missing protein in brain causes behaviours mirroring autism
"During brain development, there is a coordinated series of events that have to occur at the right time and the right place in order to establish the appropriate number of cells with the right connections," said Juan Pablo Zanin, Rutgers-Newark research associate, and lead author."
Washington D.C: Scientists have discovered that when an essential key protein needed to generate novel brain cells during pregnancy and early childhood days of the offspring is missing, which makes the brain goes haywire. This particular deprivation causes an imbalance in brain's circuitry can lead to long-term cognitive and movement behaviours characteristic of autism spectrum disorder....read more
Beware of social media: things to be avoided by doctors
10 common social media pitfalls to be avoided by doctors as per Jan. 7 article by Medscape.
1.Social media can become viral: Social media can magnify one comment. One of my 50 seconds video crossed 6.7 million in no time. It works on the principle pf 100th monkey phenomenon.
2.Never violate patient privacy by posting diagnosing patients with colleagues, posting cases on a practice website and uploading photos with a patients face or information in the background. Patients can also be identified by unusual accidents or rare conditions. Written consent is required if patients are identified for marketing or other purposes....read more
What is the importance of silence?
True silence is the silence between the thoughts and represents the true self, consciousness or the soul. It is a web of energized information ready to take all provided there is a right intent. Meditation is the process of achieving silence. Observing silence is another way of deriving benefits of meditation. Many yogis in the past have recommended and observed silence now and then. Mahatma Gandhi spent one day in silence every week. He believed that abstaining from speaking brought him inner peace and happiness. On all such days he communicated with others only by writing on paper. ....read more
Healthcare News Monitor
Mahindra logistics Ltd. (MLL), one of India’s largest 3PL solution providers, recently launched a state-of-art distribution centre for the Pharma industry in North India. With this launch, MLL forays into a first-of-its-kind temperature-controlled warehouse in the Pharma sector. Through this facility, MLL will manage the warehousing and distribution for its client, in addition to their inbound and outbound multi-modal transportation across India. The state-of-the-art warehouse is specially designed and equipped with the latest temperature control mechanisms for efficient power consumption, customized storage, diverse Material Handling Equipment (MHE) and the very latest in technological solutions, including ‘Mycargo360’, a Transport Management Systems (TMS). Rampraveen Swaminathan, CEO - Mahindra Logistics, said, “We are delighted to open this facility and we are certain that this facility will align our clients’ distribution network in North India and achieve their post-GST requirements. The facility is sustainable and energy efficient. Our integrated distribution solution combining warehousing, transportation and express movement will help our customers optimize their cost and on-time delivery”, he adds. The launch of this facility once again reinforces MLL’s expertise in logistics solutions for the pharma and consumer industries in India. MLL provides a range of services and solutions including warehousing, distribution and cross-border logistics solutions for the pharma industry. With warehousing, transportation and freight forwarding operations spanning 15 million square feet and 75000 vehicle placements per month, MLL has an extensive pan-India network and global connectivity.
The Print- Himani Chandna
The central government is looking to take action against American investigative journalist Katherine Eban, who raised questions about the Indian pharmaceutical industry in her May 2019 book Bottle of Lies. Among other things, she labelled made-in-India drugs as being of “flea-market quality” and cast doubt on the country’s image as “pharmacy of the world”, a tag it gained by producing cheaper generic versions of expensive branded drugs for diseases such as cancer. The idea of taking action against Eban was mentioned in a four-page note sent by the Central Drugs Standard Control Organisation (CDSCO), the country’s apex drug regulator, to the Ministry of Health and Family Welfare. “A brief perusal of the book reveals that there is no co-relating data available in the representing story and statements have been made based on the assumptions,” the CDSCO says in the undated note, adding that the author’s allegations were “fiction-filled stories”. Presenting several details about the status of the industry, the note, accessed by ThePrint, adds, “In view of the above, the ministry may consider taking appropriate action to counter the allegations made in the book.” The note came after the ministry last year asked the regulator to conduct an inquiry into and verify claims made by Eban amid apprehensions about the book’s possible impact on the Indian pharma industry.
A 14-hour rare liver graft transplant surgery was performed on a one-year-old girl from Saudi Arabia at Artemis Hospital in Sector 51 here. Baby Fatima (name changed) underwent the living donor liver transplant, where only 1 out of 8 portions of the liver was used to provide a new liver to her. The surgery called Monosegment (Segment 3) living donor liver transplant is the first such case reported in Delhi-NCR, in which mono-segmented liver graft has been used, the hospital said. “Apart from this, the use of bovine jugular vein in liver transplant has been reported for the first time in the world, to provide an inflow of blood to the newly transplanted liver as the baby was born with absence of bile ducts and under developed portal vein,” said a statement issued by the hospital. Managing the child during such a long surgery was a tedious and tricky task for the doctors. Born as the third child to her parents, Fatima suffered from unusually prolonged and deep jaundice for months after her birth. Doctors in Saudi Arabia diagnosed her with a rare disease called biliary atresia which is found in 1 in 16,000 live births. The developments of bile ducts in such children are absent. Fatima underwent biliary bypass surgery at a local hospital in Saudi Arabia before coming to India.
The Better India
In another life, Bengaluru-based ENT surgeon and healthcare entrepreneur Dr Kumaresh Krishnamoorthy could have become an engineer considering that’s where his inclination lay initially. But fortunately for the healthcare sector in India, he chose to study medicine. Armed with nearly two decades of professional experience and a successful practice, he caught the entrepreneurial bug three years ago. Besides augmenting his practice, he wanted to give something back to society. With his passion for engineering ever present, there was no better way to give back than developing critical low cost medical devices for patients in India. “In healthcare entrepreneurship, doctors are the best because they understand the demand and know what needs to be done. My foray into medical equipment innovation is driven by an ability to think out of the box and find solutions particularly for patients who can’t afford quality treatment. My goal is to ensure these devices reach every doctor, so that all patients, irrespective of income levels, benefit,” he tells The Better India (TBI). There are two particular devices that Dr Kumaresh Krishnamoorthy has developed that stand out—IoT-enabled video laryngoscope and the UV Bot.